Blueshift Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$272K Buy
+516
New +$289K 0.06% 408
2026
Q1
Sell
-528
Closed -$357K 567
2025
Q4
$357K Buy
+528
New +$360K 0.1% 281
2025
Q1
Sell
-1,260
Closed -$521K 473
2024
Q4
$521K Buy
+1,260
New +$553K 0.19% 152
2024
Q3
Sell
-447
Closed -$218K 415
2024
Q2
$218K Buy
+447
New +$224K 0.07% 308
2022
Q4
Sell
-813
Closed -$265K 477
2022
Q3
$265K Buy
813
+159
+24% +$58.4K 0.06% 432
2022
Q2
$229K Sell
654
-134
-17% -$54.6K 0.04% 537
2022
Q1
$431K Sell
788
-746
-49% -$392K 0.04% 488
2021
Q4
$1.01M Sell
1,534
-871
-36% -$547K 0.09% 301
2021
Q3
$1.5M Buy
2,405
+1,369
+132% +$920K 0.08% 306
2021
Q2
$654K Buy
1,036
+145
+16% +$80.1K 0.04% 476
2021
Q1
$436K Buy
+891
New +$446K 0.04% 514
2020
Q1
Sell
-2,336
Closed -$610K 430
2019
Q4
$610K Buy
+2,336
New +$616K 0.07% 399

Other funds holding IDXX

Blueshift Asset Management's IDXX Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 516 shares worth $272K. The stake represents 0.06% of the portfolio and ranks #408 among its holdings. This is a return to the name: Blueshift Asset Management previously reported a position in IDXX as recently as Q4 2025.

Blueshift Asset Management first reported a position in IDXX in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.5M in Q3 2021. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Blueshift Asset Management held 516 shares of Idexx Laboratories worth $272K as of Q2 2026.
  • Idexx Laboratories was a new Blueshift Asset Management position in Q2 2026.
  • Idexx Laboratories made up 0.06% of Blueshift Asset Management's portfolio in Q2 2026, its #408 holding.
  • Blueshift Asset Management first reported a position in Idexx Laboratories in Q4 2019 and has held it in 12 quarters since.
  • Blueshift Asset Management's Idexx Laboratories position peaked at $1.5M in Q3 2021.
  • 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.